BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moorthy H, Govindaraju T. Dendrimer Architectonics to Treat Cancer and Neurodegenerative Diseases with Implications in Theranostics and Personalized Medicine. ACS Appl Bio Mater 2021;4:1115-39. [PMID: 35014470 DOI: 10.1021/acsabm.0c01319] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Sorokina SA, Shifrina ZB. Dendrimers as Antiamyloid Agents. Pharmaceutics 2022;14:760. [DOI: 10.3390/pharmaceutics14040760] [Reference Citation Analysis]
2 Li T, Hou X, Qi Y, Duan X, Yan P, Zhu H, Xie Z, Zhang H. Nanomaterials for neurodegenerative diseases: Molecular mechanisms guided design and applications. Nano Res 2022;15:3299-322. [DOI: 10.1007/s12274-021-3865-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chandrasiri I, Loku Yaddehige M, Li B, Sun Y, Meador WE, Dorris A, Farid Zia M, Hammer NI, Flynt A, Delcamp JH, Davis E, Lippert A, Watkins DL. Cross-linking Poly(caprolactone)–Polyamidoamine Linear Dendritic Block Copolymers for Theranostic Nanomedicine. ACS Appl Polym Mater 2022;4:2972-86. [DOI: 10.1021/acsapm.1c01131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sharma M, Tiwari V, Chaturvedi S, Wahajuddin M, Shukla S, Panda JJ. Self-Fluorescent Lone Tryptophan Nanoparticles as Theranostic Agents Against Alzheimer's Disease. ACS Appl Mater Interfaces 2022;14:13079-93. [PMID: 35263093 DOI: 10.1021/acsami.2c01090] [Reference Citation Analysis]
5 Sousa CFV, Fernandez-megia E, Borges J, Mano JF. Supramolecular dendrimer-containing layer-by-layer nanoassemblies for bioapplications: current status and future prospects. Polym Chem 2021;12:5902-30. [DOI: 10.1039/d1py00988e] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Walia S, Chandrasekaran AR, Chakraborty B, Bhatia D. Aptamer-Programmed DNA Nanodevices for Advanced, Targeted Cancer Theranostics. ACS Appl Bio Mater 2021;4:5392-404. [PMID: 35006722 DOI: 10.1021/acsabm.1c00413] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Padhi D, Govindaraju T. Mechanistic Insights for Drug Repurposing and the Design of Hybrid Drugs for Alzheimer's Disease. J Med Chem 2022. [PMID: 35559617 DOI: 10.1021/acs.jmedchem.2c00335] [Reference Citation Analysis]